Rapid pumping of urokinase in the catheter-directed thrombolysis for the management of acute deep vein thrombosis

Wendong Li,Chen Liu,Kun Jiang,Tong Qiao,Feng Ran,Cheng Liu,Zhao Liu,Chenglong Li,Xiaoqiang Li
DOI: https://doi.org/10.3760/cma.j.issn.2096-1863.2018.04.004
2018-01-01
Abstract:Objective To investigate the role of rapid pumping of urokinase in catheter-directed thrombolysis (CDT) for the management of acute deep vein thrombosis (DVT). Methods Between January 2016 and January 2018, patients who were diagnosed with acute lower extremity DVT and performed with CDT were included in this retrospective study. Those patients were divided into two groups via the different ways of urokinase usage. Data including the effects of thrombolysis, complications and post-thrombotic syndrome (PTS) incidence rate were compared to find out the proper way of urokinase usage for acute DVT. Result A total of 146 patients were involved in this study. Among them, 52 cases were performed with rapid pumping of urokinase. The duration of thrombolysis in the two groups were (4.90±1.25) days and (5.52±1.60) days, respectively(P=0.001). Reduction of fibrinogen concentration were (1.99±1.01)g/L and (2.48±1.25) g/L respectively(P=0.015). The speed of D-dimer promotion were (7.63±2.60) mg·L-1·d-1 and (6.61±1.16) mg·L-1·d-1, respectively (P=0.009). But it had no effect on concentration of D-dimer, platelet account, dosage of urokinase and complications and PTS incidence. Conclusion The way of rapid pumping urokinase in CDT is a safe and effective way to remove the acute thrombosis. Compared with continuity thrombolysis, it has less impairment on fibrinogen. It could shorten the duration of thrombolysis but had no effect on complications and PTS.
What problem does this paper attempt to address?